• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用编码牛病毒性腹泻病毒E2蛋白截短的分泌形式的质粒DNA进行免疫接种可引发强烈的体液免疫和细胞免疫反应。

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.

作者信息

Liang Rong, van den Hurk Jan V, Zheng Chunfu, Yu Hong, Pontarollo Reno A, Babiuk Lorne A, van Drunen Littel-van den Hurk Sylvia

机构信息

Vaccine and Infectious Disease Organization, University of Saskatchewan, Sask., Canada S7N 5E3.

出版信息

Vaccine. 2005 Nov 1;23(45):5252-62. doi: 10.1016/j.vaccine.2005.06.025. Epub 2005 Jul 13.

DOI:10.1016/j.vaccine.2005.06.025
PMID:16154245
Abstract

The major protective antigen of bovine viral diarrhea virus (BVDV), the E2 protein, is cell-associated and not expressed on the cell surface. In this study we evaluated a DNA vaccine encoding various secreted versions of E2. In vitro analysis demonstrated that deletion of the transmembrane anchor and addition of the signal sequence of bovine herpesvirus-1 (BHV-1) (gDsDeltaE2) resulted in efficient secretion of E2 into the culture medium. In contrast, full-length E2, either without or with gDs (gDsE2), as well as truncated E2 without gDs (DeltaE2), remained entirely cell-associated. Mice immunized with plasmid encoding gDsDeltaE2 developed significantly higher IgG and virus neutralizing antibody titres compared to animals vaccinated with plasmid encoding E2, DeltaE2 or gDsE2. To optimize secretion of E2, the efficiency of gDs was compared with that of the tissue plasminogen activator signal (tPAs) sequence. In addition, the effect of the plasmid backbone was assessed by comparing two vectors. Four plasmids, pMASIA-gDsDeltaE2, pMASIA-tPAsDeltaE2, pSLKIA-gDsDeltaE2 and pSLKIA-tPAsDeltaE2, were constructed and administered intradermally to mice. The mice immunized with pMASIA-tPAsDeltaE2 developed the strongest and most balanced immune responses. Vaccination of cattle confirmed that pMASIA-tPAsDeltaE2 elicited both strong humoral and cellular immune responses and thus could be a candidate DNA vaccine against BVDV.

摘要

牛病毒性腹泻病毒(BVDV)的主要保护性抗原E2蛋白与细胞相关,不在细胞表面表达。在本研究中,我们评估了一种编码各种分泌型E2的DNA疫苗。体外分析表明,删除跨膜锚定区并添加牛疱疹病毒-1(BHV-1)的信号序列(gDsDeltaE2)可使E2有效分泌到培养基中。相比之下,全长E2(无论有无gDs,即gDsE2)以及无gDs的截短型E2(DeltaE2)仍完全与细胞相关。与接种编码E2、DeltaE2或gDsE2质粒的动物相比,用编码gDsDeltaE2的质粒免疫的小鼠产生的IgG和病毒中和抗体滴度显著更高。为了优化E2的分泌,将gDs的效率与组织纤溶酶原激活剂信号(tPAs)序列的效率进行了比较。此外,通过比较两种载体评估了质粒骨架的作用。构建了四种质粒pMASIA-gDsDeltaE2、pMASIA-tPAsDeltaE2、pSLKIA-gDsDeltaE2和pSLKIA-tPAsDeltaE2,并将其皮内注射给小鼠。用pMASIA-tPAsDeltaE2免疫的小鼠产生了最强且最平衡的免疫反应。牛的疫苗接种证实,pMASIA-tPAsDeltaE2能引发强烈的体液免疫和细胞免疫反应,因此可能是一种抗BVDV的候选DNA疫苗。

相似文献

1
Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.用编码牛病毒性腹泻病毒E2蛋白截短的分泌形式的质粒DNA进行免疫接种可引发强烈的体液免疫和细胞免疫反应。
Vaccine. 2005 Nov 1;23(45):5252-62. doi: 10.1016/j.vaccine.2005.06.025. Epub 2005 Jul 13.
2
Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.在单一DNA疫苗制剂中编码1型和2型牛病毒性腹泻病毒E2的质粒的兼容性
Vaccine. 2007 Aug 10;25(32):5994-6006. doi: 10.1016/j.vaccine.2007.05.036. Epub 2007 Jun 11.
3
[Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].[小鼠Fms样酪氨酸激酶3配体增强对编码丙型肝炎病毒核心和包膜2融合抗原的DNA疫苗的细胞免疫应答]
Sheng Wu Gong Cheng Xue Bao. 2003 Mar;19(2):158-62.
4
A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.一种组合的牛疱疹病毒1型gB - gD DNA疫苗在小鼠中诱导免疫反应。
Comp Immunol Microbiol Infect Dis. 2005 Mar;28(2):155-66. doi: 10.1016/j.cimid.2004.10.001.
5
Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.肉牛对二价灭活牛病毒性腹泻病毒疫苗的体液免疫和T细胞介导的免疫反应。
Vet Immunol Immunopathol. 2008 Mar 15;122(1-2):8-15. doi: 10.1016/j.vetimm.2007.11.009. Epub 2007 Dec 3.
6
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.用编码与组织纤溶酶原激活剂信号序列融合的甲型流感病毒核蛋白的质粒DNA进行免疫接种,可在小鼠体内引发强烈的免疫反应并提供针对H5N1攻击的保护。
J Virol Methods. 2008 Dec;154(1-2):121-7. doi: 10.1016/j.jviromet.2008.08.011. Epub 2008 Sep 27.
7
Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.一种改良活病毒疫苗诱导针对牛呼吸道疾病病毒的抗原特异性T细胞亚群活化
Am J Vet Res. 2006 Jul;67(7):1179-84. doi: 10.2460/ajvr.67.7.1179.
8
Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD.用牛疱疹病毒4型载体分泌嵌合肽BVDV-E2/BoHV-1-gD的双重免疫策略
Vaccine. 2008 Nov 11;26(48):6031-42. doi: 10.1016/j.vaccine.2008.09.023. Epub 2008 Sep 21.
9
The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection.编码牛疱疹病毒1糖蛋白B的质粒诱导的细胞介导免疫反应,当通过肌肉注射或基因枪递送时,会被编码IL-12的质粒增强,但皮内注射后则不会。
Vaccine. 2006 Jun 19;24(25):5349-59. doi: 10.1016/j.vaccine.2006.04.026. Epub 2006 May 3.
10
Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle.用编码E2的DNA进行初免,并用与CpG寡脱氧核苷酸配制的E2蛋白进行加强免疫,可诱导牛产生强烈的免疫反应并预防牛病毒性腹泻病毒。
J Gen Virol. 2006 Oct;87(Pt 10):2971-2982. doi: 10.1099/vir.0.81737-0.

引用本文的文献

1
Unveiling the Role of Bovine Herpesvirus Type 4 (BHV-4) in Dairy Cow Reproductive Disorders: Insights From a Multifaceted Study in China.揭示牛4型疱疹病毒(BHV-4)在奶牛繁殖障碍中的作用:来自中国一项多方面研究的见解
Transbound Emerg Dis. 2024 Dec 27;2024:4048149. doi: 10.1155/tbed/4048149. eCollection 2024.
2
Identification of NECTIN1 as a novel restriction factor for flavivirus infection.鉴定NECTIN1为黄病毒感染的一种新型限制因子。
mBio. 2024 Dec 11;15(12):e0270824. doi: 10.1128/mbio.02708-24. Epub 2024 Nov 21.
3
Immune evasion strategies of bovine viral diarrhea virus.
牛病毒性腹泻病毒的免疫逃逸策略。
Front Cell Infect Microbiol. 2023 Oct 13;13:1282526. doi: 10.3389/fcimb.2023.1282526. eCollection 2023.
4
The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine.疫苗与佐剂联合使用以预防牛群中高发性传染病的发生。
Front Vet Sci. 2023 Oct 11;10:1243835. doi: 10.3389/fvets.2023.1243835. eCollection 2023.
5
Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis.牛病毒性腹泻病毒的异质性及其对疫苗接种和诊断的潜在影响。
Viruses. 2020 Oct 6;12(10):1134. doi: 10.3390/v12101134.
6
Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.牛病毒性腹泻病毒 E2 蛋白重组干酪乳杆菌 W56 与霍乱毒素 B 亚单位联合作为佐剂的免疫原性评价。
Microb Cell Fact. 2020 Oct 1;19(1):186. doi: 10.1186/s12934-020-01449-3.
7
Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine.优化的 M2e DNA 疫苗对同源和异源甲型流感病毒的保护作用。
Emerg Microbes Infect. 2019;8(1):45-54. doi: 10.1080/22221751.2018.1558962.
8
Immunization with Brugia malayi Myosin as Heterologous DNA Prime Protein Boost Induces Protective Immunity against B. malayi Infection in Mastomys coucha.用马来布鲁线虫肌球蛋白进行异源DNA初免-蛋白加强免疫可诱导多乳鼠对马来布鲁线虫感染产生保护性免疫。
PLoS One. 2016 Nov 9;11(11):e0164991. doi: 10.1371/journal.pone.0164991. eCollection 2016.
9
Challenges in Veterinary Vaccine Development and Immunization.兽医疫苗开发与免疫接种中的挑战。
Methods Mol Biol. 2016;1404:3-35. doi: 10.1007/978-1-4939-3389-1_1.
10
Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.工程化异源抗原的细胞靶向是基于牛疱疹病毒4的疫苗载体开发的决定性因素。
Clin Vaccine Immunol. 2009 Nov;16(11):1675-86. doi: 10.1128/CVI.00224-09. Epub 2009 Sep 30.